Helicobacter pylori and functional dyspepsia: A real causal link?

Bailliere's Clinical Gastroenterology

Volumn 12, Issue 3, 1998, Pages 503-532

  Pantoflickova, Drahoslava ^b   Blum, André L ^a,b   Koelz, Hans R ^a,c  

^a Department of Medicine

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c TRIEMLI HOSPITAL   (Switzerland)

Author keywords

Epidemiology; Functional dyspepsia; Helicobacter pylori; Pathophysiology; Treatment

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; BISMUTH CITRATE; BISMUTH SALICYLATE; CLARITHROMYCIN; GASTRIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; TETRACYCLINE; TINIDAZOLE;

ARTICLE; CLINICAL TRIAL; DYSPEPSIA; GASTRIN RELEASE; GASTROINTESTINAL MOTILITY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; META ANALYSIS; METHODOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIDE EFFECT; STOMACH ACID SECRETION; STOMACH PH; SYMPTOM; VISCERA;

EID: 0031731319     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(98)90021-5     Document Type: Article

References (141)

1. Abd Alla K, Afaf H & Fatma B (1997) Gastric emptying, antroduodenal motility and histopathological study of patients with (ulcer like) functional dyspepsia: correlation with severity of symptoms. Gut 41 (supplement 3): P710 (abstract).
2. Agréus L, Engstrand L, Svärdsudd K et al (1995) Helicobacter pylori seropositivity among Swedish adults with and without abdominal symptoms. A population-based epidemiologic study. Scandinavian Journal of Gastroenterology 30: 752-757.
3. Arakawa T, Watanabe T & Kobayashi K (1997) Regulation of acid secretion and peptic ulcer formation by inflammatory cytokines. In Ernst PB, Michetti P & Smith PD (eds) The Immunology of H. pylori: from Pathogenesis to Prevention, pp 183-199. Philadelphia: Lippincott-Raven.
4. Armstrong D (1996) Helicobacter pylori infection and dyspepsia. Scandinavian Journal of Gastroenterology 31 (supplement 215): 38-47.
5. Aspiroz F (1990) Functional dyspepsia: recent pathophysiological advances. Acta GastroEnterologica Belgica 53: 518-522.
6. Bates S, Sjöden P, Fellenius J et al (1989) Blocked and non-blocked acid secretion and reported pain in ulcer, non-ulcer dyspepsia, and normal subjects. Gastroenterology 97: 376-383.
7. Bayerdörffer E, Lehn N, Hatz R et al (1992) Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 102: 1575-1582.
8. Bazzoli F, Zagari RM, Festi D et al (1997) A population based study of Helicobacter pylori infection. II. Prevalence by 13 C-urea breath test and association with dyspeptic symptoms. Gut 41 (supplement 3): P116.
9. Beales I, Blaser MJ, Srinivasan S et al (1997) Effect of Helicobacter pylori products and recombinant cytokines on gastrin release from cultured canine G cells. Gastroenterology 113: 465-471.
10. Bechi P, Dei R, Amorosi A et al (1992) Helicobacter pylori and luminal gastric pH. Relationships in nonulcer dyspepsia. Digestive Diseases and Sciences 37: 378-384.
11. Bernersen B, Johnsen R, Bostad L et al (1992) Is Helicobacter pylori the cause of dyspepsia? British Medical Journal 304: 1276-1279.
12. Bianchi-Porro G & Parente F (1995) Nature of non-ulcer dyspepsia and related conditions. Baillière's Clinical Gastroenterology 9: 549-562.
13. Blum AL, Arnold R, Koelz HR et al (1997) Treatment of functional dyspepsia (FD) with omeprazole and ranitidine. Gastroenterology 110: A73 (abstract).
14. Börsch G, Schmidt G, Wegener M et al (1988) Campylobacter pylori: prospective analysis of clinical and histological factors associated with colonization of the upper gastrointestinal tract. European Journal of Clinical Investigation 18: 133-138.
15. Braden B, Caspary WF & Lembcke B (1997) Density of gastric Helicobacter pylori colonization is not associated with occurrence of dyspeptic symptoms. Digestive Diseases and Sciences 42: 2120-2123.
16. Bueno L, Fioramonti J, Delvaux M et al (1997) Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 112: 1714-1743.
17. Caballero-Plasencia AM, Muros-Navarro MC, Martin-Ruiz JL et al (1995) Dyspeptic symptoms and gastric emptying of solids in patients with functional dyspepsia. Role of Helicobacter pylori infection. Scandinavian Journal of Gastroenterology 30: 745-751.
18. Calam J, Gibbons A, Healey Z et al (1997) How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology. Gastroenterology 113: S43-S49.
19. Chang CS, Chen GH, Kao CH et al (1996) The effect of Helicobacter pylori infection on gastric emptying of digestible and non digestible solids in patients with non ulcer dyspepsia. American Journal of Gastroenterology 91: 474-479.
20. Cheli R, Crespi M, Testino G et al (1998) Gastric cancer and Helicobacter pylori: biologic and epidemiologic inconsistencies. Journal of Clinical Gastroenterology 26: 3-6.
21. Coffin B, Azpiroz F, Guarner F et al (1994) Selective gastric hypersensitivity and reflex hyporeactivity in functional dyspepsia. Gastroenterology 107: 1345-1351.
22. Collen MJ & Loebenberg MJ (1989) Basal gastric acid secretion in non-ulcer dyspepsia with or without duodenitis. Digestive Diseases and Sciences 34: 246-250.
23. Collins SM (1996) The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 111: 1683-1699.
24. Collins JS, Hamilton PW, Watt PC et al (1989) Superficial gastritis and Campylobacter pylori in dyspeptic patients - a quantitative study using computer-linked image analysis. Journal of Pathology 158: 303-310.
25. Czinn SJ, Bertram TA, Murray PD & Yang P (1991) Relationship between gastric inflammatory response and symptoms in patients infected with Helicobacter pylori. Scandinavian Journal of Gastroenterology 26 (supplement 181): 33-37.
26. Dixon M (1995) Histological responses to Helicobacter pylori infection: gastritis, atrophy and paraneoplasia. Baillière's Clinical Gastroenterology 9: 467-485.
27. Dobrilla G, Comberlato M, Steele A et al (1989) Drug treatment in functional dyspepsia. A metaanalysis of randomized controlled trials. Journal of Clinical Gastroenterology 11: 169-177.
28. Dooley CP, Arandia D, Dehesa M et al (1990) An evaluation of the role of Helicobacter pylori infection in nonulcer dyspepsia. Gastroenterology 98: A37.
29. El-Omar E, Penman ID, Ardill JES et al (1995) A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut 36: 534-538.
30. Elta GH, Scheiman JM, Barnett JL et al (1995) Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients. American Journal of Gastroenterology 90: 1089-1093.
31. Fock KM, Khoo TK, Chia KS & Sim CS (1997) Helicobacter pylori infection and gastric emptying in indigestible solids in patients with dysmotility-like dyspepsia. Scandinavian Journal of Gastroenterology 32: 676-680.
32. Frazzoni M, Lonardo A, Grisendi A et al (1993) Are routine duodenal and antral biopsies useful in the management of 'functional' dyspepsia? A diagnostic and therapeutic study. Journal of Clinical Gastroenterology 17: 101-108.
33. Gasbarrini A, de Luca A, Ojetti V et al (1997) Incidence and symptoms related to Helicobacter pylori infection in dyspeptic patients Gastroenterology 112: A124 (abstract).
34. George AA, Tsuchiyose M & Doodley CP (1991) Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia. Gastroenterology 101: 3-6.
35. Gilvarry J, Buckley MJM, Beattie S et al (1997) Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scandinavian Journal of Gastroenterology 32: 535-540.
36. Glasbrenner B, Malfertheiner P, Nilius M et al (1996) Prevalence of Helicobacter pylori infection and dyspepsia in young adults in Germany. Zeitchrift für Gastroenterologie 34: 478-482.
37. Goddard AF, Lawes S & Spiller RC (1997) One year follow-up of one-week, low-dose triple therapy in ulcer disease and non-ulcer dyspepsia: re-infection, dyspeptic symptoms and medication. Gut 41 (supplement 3): A22 (abstract).
38. Goh KL, Parasakthi N, Peh SC et al (1991) Helicobacter pylori infection and non-ulcer dyspepsia: the effect of treatment with colloidal bismuth subcitrate. Scandinavian Journal of Gastroenterology 26: 1123-1131.
39. Goh KL, Paramsothy M, Parasakthi N et al (1997) Does Helicobacter pylori infection affect gastric emptying in patients with functional dyspepsia? Journal of Gastroenterology and Hepatology 12: 790-794.
40. Graham Y (1997) The only good Helicobacter pylori is a dead Helicobacter pylori. Lancet 350: 70-71.
41. Guitiérrez O, Sierra F, Gomez MC et al (1988) Campylobacter pylori in chronic environmental gastritis and duodenal ulcer patients. Gastroenterology 94: A163.
42. Harris PR & Smith PD (1997) The role of the mononuclear phagocyte in H. priori-associated infection. In Ernst PB, Michetti P & Smith PD (eds) The Immunology of H. pylori: from Pathogenesis to Prevention, pp 127-137. Philadelphia: Lippincott-Raven.
43. Heading RC (1991) Definitions of dyspepsia. Scandinavian Journal of Gastroenterology 182 (supplement): 1-6.
44. Heaney A, Collins JS & Tham TCK (1997) Dyspepsia scores, quality of life and personality traits are similar in H. pylori positive and H. pylori negative patients. Gut 41 (supplement 3): 712.
45. Heikkinen M, Mayo K, Mégraud F et al (1998) Association of CagA positive and CagA negative H. pylori strains with patient's symptoms and gastritis in primary care patients with functional upper abdominal complains. Scandinavian Journal of Gastroenterology 33: 31-38.
46. Holtmann G, Talley NJ & Goebell H (1996) Association between H. pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia. Digestive Diseases and Sciences 41: 1285-1291.
47. Holtmann G, Goebell H, Holtmann M et al (1994) Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Digestive Diseases and Sciences 39: 1090-1098.
48. Hovelius B, Andersson SI, Hagander B et al (1994) Dyspepsia in general practice: history and symptoms in relation to Helicobacter pylori serum antibodies. Scandinavian Journal of Gastroenterology 29: 506-510.
49. van der Hulst RW, van der Ende A, Dekker FW et al (1997) Effect of Helicobacter pylori eradication on gastritis in relation to CagA: a prospective 1-year follow-up study. Gastroenterology 113: 25-30.
50. Johnsen R, Bernersen B, Straume B et al (1991) Prevalences of endoscopie and histological findings in subjects with and without dyspepsia. British Medical Journal 302: 749-752.
51. Kang JY, Tay HH, Wee A et al (1990) Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double-blind placebo controlled study. Gut 31: 476-480.
52. Kazi JI, Jafarey NA, Alam SM et al (1990) A placebo controlled trial of bismuth salicylate in Helicobacter pylori associated gastritis. Journal of the Pakistan Medical Association 40: 154-156.
53. Klatt S, Pieramico O, Guethner C et al (1997) Gastric hypersensitivity in nonulcer dyspepsia. An inconsistent finding. Digestive Diseases and Sciences 42: 720-723.
54. Klauser AG, Voderholzer WA, Knesewitsch PA et al (1993) What is behind dyspepsia? Digestive Diseases and Sciences 38: 147-154.
55. Koelz HR, Arnold R, Stolte M & Blum AL (1998) Treatment of Helicobacter pylori does not improve symptoms of functional dyspepsia. Gastroenterology 114: G0747.
56. Konturek JW, Fischer H, Riemann B et al (1997) Effects of eradication of Helicobacter pylori (Hp) on gastric secretory and motor functions in patients with non-ulcer-dyspepsia Gut 41 (supplement 1): A17 (abstract).
57. Kuipers EJ (1997) Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Alimentary Pharmacology and Therapeutics 11 (supplement 1): 71-88.
58. Labenz J, Blum AL, Bayerdörffer E et al (1997) Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112: 1442-1447.
59. Lambert JR, Dunn K, Borromeo M et al (1989) Campylobacter pylori - a role in non-ulcer dyspepsia? Scandinavian Journal of Gastroenterology 24 (supplement 160): 7-13.
60. Lauritsen K, Aalykke C & Havelund T (1996) Effect of omeprazole in functional dyspepsia: a double blind, placebo-control study. Gastroenterology 110 (supplement 4): A702 (abstract).
61. Lazzaroni M, Bargiggia S, Sangaletti O et al (1996) Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopie study. Digestive Diseases and Sciences 41: 1589-1594.
62. Leontiadis G, Minopoulos G, Maltezos E et al (1997) Study of gastric emptying in patients with non-ulcer dyspepsia evaluated by paracetamol absorption technique: preliminary results. Gut 41 (supplements 3): P381.
63. Lichtenberg LM, Dial EJ, Romero JJ et al (1995) Role of luminal ammonia in the development of gastropathy and hypergastrinemia in the rat. Gastroenterology 108: 320-329.
64. Lin HC (1992) Disordered gastric motility and emptying. In Gitnick G (ed.) Principles and Practice of Gastroenterology and Hepatology, pp 65-66. New York: Elsevier.
65. Loffeld RJLF, Potters HVJP, Arends JW et al (1988) Campylobacter associated gastritis in patients with non-ulcer dyspepsia. Journal of Clinical Pathology 41: 85-88.
66. Loffeld RJLF, Potters HVJP, Stobberingh E et al (1989) Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind, placebo controlled trial with colloidal bismuth subcitrate. Gut 30: 1206-1212.
67. McCarthy C, Patchett S, Collins MR et al (1995) Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Digestive Disease and Sciences 40: 114-119.
68. McColl KEL, Murray LS, El Omar E et al (1998) UK trial of H pylori eradication therapy for non-ulcer dyspepsia (abstract). Gut 42 (supplement 1): A3.
69. McNulty CAM, Gearty JC, Crump B et al (1986) Campylobacter pyloridis and associated gastritis: investigator blind placebo-controlled trial of bismuth salicylate and erythromycin ethylsuccinate. British Medical Journal 293: 645-649.
70. Malagelada JR (1991) Gastro-intestinal motor disturbances in functional dyspepsia. Scandinavian Journal of Gastroenterology 26 (supplement 182): 29-32.
71. Marshall BJ, Armstrong JA, McGechie DB et al (1985) Attempt to fulfil Koch's postulates for pyloric Campylobacter. Medical Journal of Australia 142: 436-439.
72. Mayer EA & Gebhart GF (1994). Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107: 271-293.
73. Mearin F, Cucala M, Azpiroz F et al (1991) The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 101: 999-1006.
74. Mearin F, de Ribot X, Balboa A et al (1995) Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia? Gut 37: 47-51.
75. Mégraud F, Branssens-Rabbe MP, Denis F et al (1989) Seroepidemiology of Campylobacter pylori infection in various populations. Journal of Clinical Microbiology 27: 1870-1873
76. Moayyedi P, Braunholtz D, Atha P et al (1998) What proportion of dyspepsia in the general population is attributable to Helicobacter pylori? Gut 42 (supplement 1): A75 (abstract).
77. Morris A & Nicholson G (1987) Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. American Journal of Gastroenterology 82: 192-199.
78. Murakami K, Fujioka T, Shiota K et al (1995) Influence of Helicobacter pylori infection and effects on its eradication on gastric emptying in non-ulcerative dyspepsia. European Journal of Gastroenterology and Hepatology 7 (supplement 1): S93-S97.
79. Nafeeza MI, Shahimi MM, Kudva MV et al (1992) Evaluation of therapies in the treatment of Helicobacter pylori associated non-ulcer dyspepsia. Singapore Medical Journal 33: 570-574.
80. Nandurkar S, Talley NJ, Xia HH et al (1997) Dyspepsia in the community is linked to smoking and aspirin use but not H. pylori. Gastroenterology 112: A232.
81. Noach LA, Bosma NB, Jansen J et al (1994) Mucosal tumor necrosis factor alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scandinavian Journal of Gastroenterology 29: 425-429.
82. Oderda G, Rapa A & Chiorebioli E (1997) The only good Helicobacter pylori is a dead Helicobacter pylori. Lancet 350: 71.
83. Ohkusa T, Takashimizu I, Fujiki K et al (1997) Changes in serum pepsinogen, gastrin and immunoglobulin antibody titres in Helicobacter positive gastric ulcer after eradication of infection. Journal of Clinical Gastroenterology 25: 317-322.
84. Olbe L & Malfertheiner P (1996) Gastric pathophysiology - emphasis on acid secretion and gastro-intestinal motility. Current Opinion in Gastroenterology 12 (supplement 1): 16-20.
85. Ota H & Genta RM (1997) Morphological characterization of the gastric mucosa during infection with H. pylori. In Ernst PB, Michetti P, Smith PD (eds) The Immunology of H. pylori: from Pathogenesis to Prevention, pp 15-27. Philadelphia: Lippincott-Raven.
86. Parente F, Maconi G, Sangaletti O et al (1995) Behavior of acid secretion, gastrin release, serum pepsinogen I, gastric emptying of liquids over six months from eradication of Helicobacter pylori in duodenal ulcer patients. A controlled study. Gut 37: 210-215.
87. Parente F, Cucino C, Imbesi V et al (1998) Effects of H. pylori on gastric function indices in functional dyspepsia (FD). A prospective controlled study. Gut 42 (supplement 1): A5 (abstract).
88. Parsonnet J, Blaser MJ, Perez-Perez GI et al (1992) Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 102: 41-46.
89. Patchett S, Beattie S, Leen E et al (1991) Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. British Medical Journal 303: 1238-1240.
90. Peitz U, Blaudszun S, Aygen S et al (1996) No significant change of delayed gastric emptying of digestible and indigestible solids in patients with non-ulcer dyspepsia. Gastroenterology 110: A733.
91. Pereira Lima JG, Scoll J, Pinheiro JB et al (1995) Helicobacter-pylori associated gastritis: does it play a role in functional dyspepsia? Zeitschrift für Gastroenterologie 33: 421-425.
92. Pérez-Paramo M, Albillos A, Calleja JL et al (1997) Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy. Digestive Diseases and Sciences 42: 1734-1740.
93. Peterson WL, Barnett C & Evans DJ (1993) Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. American Journal of Gastroenterology 88: 2038-2043.
94. Pettross CW, Appleman MD, Cohen H et al (1988) Prevalence of Campylobacter pylori and association with antral mucosa histology in subject with and without upper gastrointestinal symptoms. Digestive Diseases and Sciences 33: 649-653.
95. Pfaffenbach B, Adamek JR & Bartholomäus CH et al (1997) Gastric dysrhythmias and delayed gastric emptying in patients with functional dyspepsia. Digestive Diseases and Sciences 42: 2094-2099.
96. Pfeiffer A, Aronbayev J, Schmidt T et al (1992) Gastric emptying, esophageal 24-hour pH and gastric potential difference measurements in non-ulcer dyspepsia. Gastroenterologie Clinique et Biologique 16: 395-400.
97. Pieramico O, Ditschuneit H & Malfertheiner P (1993) Gastrointestinal motility in patients with non-ulcer dyspepsia: a role for Helicobacter pylon infection? American Journal of Gastroenterology. 88: 364-368.
98. Quigley E (1996) Gastric and small intestinal motility in health and disease. Gastroenterology Clinics of North America. 25: 113-145.
99. Qvist N, Rasmussen L & Axelsson C (1994) Helicobacer pylori-associated gastritis and dyspepsia. Scandinavian Journal of Gastroenterology 29: 133-137.
100. Rathbone BJ, Wyatt J & Heatley RV (1988) Symptomatology in C. pylori-positive and negative non-ulcer dyspepsia. Gut 29: A1473.
101. Rauws EA, Langenberg W, Houthoff HJ et al (1988) Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94: 33-40.
102. Rokkas T, Pursey C, Uzoechina E et al (1987) Campylobacter pylori and non-ulcer dyspepsia. American Journal of Gastroenterology 82: 1149-1152.
103. Rokkas T, Pursey C, Uzoechina E et al (1988) Non-ulcer dyspepsia and short-term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori. Gut 29: 1386-1391.
104. Rosenstock S, Kay L, Rosenstock C et al (1997) Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut 41: 169-176.
105. Schlemper RJ, Itabashi M, Kato Y et al (1997) Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet 349: 1725-1729.
106. Schubert TT & Schubert AA (1992) Symptoms, gastritis and Helicobacter pylori in patients referred for endoscopy. Gastrointestinal Endoscopy 38: 357-360.
107. Schutze K, Hentschel E & Hirschl AM (1995) Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia. European Journal of Gasteoenterology and Hepatology 8: 41-46.
108. Scott AM, Kellow JE, Shuter B et al (1993) Intragastric distribution and gastric emptying of solids and liquids in functional dyspepsia. Lack of influence of symptom subgroups and H. pylori-associated gastritis. Digestive Diseases and Sciences 38: 2247-2254.
109. Sheu BS, Lin CY, Lin XZ et al (1996) Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment (see comments). American Journal of Gastroenterology 91: 441-447.
110. Small PK, Loudon MA, Waldron B et al (1995) Importance of reflux symptoms in functional dyspepsia. Gut 36: 189-192.
111. Sobala GM, Dixon MF & Axon ATR (1990) Symptomatology of Helicobacter pylori-associated dyspepsia. European Journal of Gastroenterology and Hepatology 2: 445-449.
112. Sobala GM, Crabtree JE, Dixon MF et al (1991) Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 32: 1415-1418.
113. Stein C (1995) The control pain in peripheral tissue by opioids. New England Journal of Medicine 322: 1685-1690.
114. Stolte M (1997) Diagnosis of gastric carcinoma in Japan and western countries. Lancet 350: 448.
115. Strauss RM, Wang TC, Kelsey PB (1990) Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. American Journal of Medicine 89: 464-469.
116. Tack J, Piessevaux H & Coulie B (1998) Helicobacter pylori, symptom severity and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 114: G1231.
117. Talley NJ (1994) A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 106: 1174-1183.
118. Talley NJ (1998) Cure of H. pylori does not abolish symptoms in non-ulcer dyspepsia: a randomized double-blind placebo controlled trial with 12 months follow-up. Gastroenterology 114: G1249.
119. Talley NJ & Hunt RH (1997) What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms. Gastroenterology 113: S67-S77.
120. Talley NJ & Phillips SF (1988) Non-ulcer dyspepsia: potential causes and pathophysiology. Annals of Internal Medicine 108: 865-879.
121. Talley NJ, Shuter B & McCrudden G (1989) Lack of association between gastric emptying of solids and symptoms in nonulcer dyspepsia. Journal of Clinical Gastroenterology 11: 625-630.
122. Talley NJ, Zinsmeister AR & Schleck CD (1992) Dyspepsia and dyspepsia subgroups: a population based study. Gastroenterology 102: 1259-1268.
123. Talley NJ, Janssens J & Lauritsen K (1998) Long-term follow-up of patients with non-ulcer dyspepsia after H. pylori eradication. A randomized double-blind placebo controlled trial. Gastroenterology 114: G1249.
124. Testoni PA, Bagnolo F, Bologna Pet al (1996) Helicobacter pylori infection in dyspeptic patients who do not have gastric III phase of the migrating motor complex. Scandinavian Journal of Gastroenterology 31: 1063-1068.
125. Thor P, Lorens K, Tabor R et al (1996) Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with non-ulcer dyspepsia. Journal of Physiology and Pharmacology 47: 469-476.
126. Thürmer HL, Flaaten B, Erichsen KE et al (1996) Helicobacter pylori infection in non-ulcer dyspeptic and ulcer patients. Determinants and consequences in 'real life'. Scandinavian Journal of Gastroenterology 31: 744-748.
127. Trespi E, Broglia F, Villani L et al (1994) Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication. Scandinavian Journal of Gastroenterology 29: 884-888.
128. Tsega E, Gebre W, Manley P et al (1996) Helicobacter pylori, gastritis and non-ulcer dyspepsia in Ethiopian patients. Ethiopian Medical Journal 34: 65-71.
129. Tucci A, Corinaldesi R, Stanghellini V et al (1992) Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 103: 768-774.
130. Vaira D, Holton J, Osborn J et al (1990) Endoscopy in dyspeptic patients: is gastric mucosal biopsy useful? American Journal of Gastroenterology 85: 701-704.
131. Vaira D, Holton J, Falzon M et al (1992) Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia. Italian Journal of Gastroenterology 24: 400-404.
132. Veldhuyzen van Zanten SJO (1997) The role of Helicobacter pylori infection in non ulcer dyspepsia. Alimentary Pharmacology and Therapeutics 11 (supplement 1): 63-69.
133. Verdú EF, Fraser R, Tiberio D et al (1996a) Prevalence of Helicobacter pylori infection and chronic dyspeptic symptoms among immigrants from developing countries and people born in industrialized countries. Digestion 57: 180-185.
134. Verdú EF, Armstrong D, Idström JP et al (1996b) Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis. Scandinavian Journal of Gastroenterology 31: 1151-1156.
135. Verhulst MI, Hopman WPM, Tangerman A et al (1995) Eradication of Helicobacter pylori infection in patients with non-ulcer dyspepsia. Scandinavian Journal of Gastroenterology 30: 968-973.
136. Vuyyuru L, Scubert ML, Harrington L et al (1995) Dual inhibitory pathways link antral somatostatin and histamine secretion in human, dog and rat stomach. Gastroenterology 109: 1566-1574.
137. Waldron B, Cullen PT, Kumar R et al (1991) Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study. Gut 32: 246-251.
138. Watkins LR, Maier SF & Goehler LE (1995) Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63: 289-302.
139. Wegener M, Börsch G, Schaffstein J et al (1988) Are dyspeptic symptoms in patients with Campylobacter pylori-associated type B gastritis linked to delayed gastric emptying? American Journal of Gastroenterology 83: 737-740.
140. Westblom TU, Maden E, Subik MA et al (1992) Double-blind randomized trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection. Scandinavian Journal of Gastroenterology 27: 249-252.
141. Wilhelmsen I, Tangen Haug T, Sipponen P & Berstad A (1994) Helicobacter pylon in functional dyspepsia and normal controls. Scandinavian Journal of Gastroenterology 29: 522-527.